GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:0003222 | ventricular trabecula myocardium morphogenesis | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:0003223 | ventricular compact myocardium morphogenesis | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:0003226 | right ventricular compact myocardium morphogenesis | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:0021553 | olfactory nerve development | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:0035909 | aorta morphogenesis | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:0043584 | nose development | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:0048752 | semicircular canal morphogenesis | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:0062009 | secondary palate development | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:2000269 | regulation of fibroblast apoptotic process | 50.0% (1/2) | 12.67 | 0.000153 | 0.003805 |
GO:0035042 | obsolete fertilization, exchange of chromosomal proteins | 50.0% (1/2) | 12.25 | 0.000205 | 0.004439 |
GO:0070016 | armadillo repeat domain binding | 50.0% (1/2) | 12.25 | 0.000205 | 0.004439 |
GO:0035176 | social behavior | 50.0% (1/2) | 11.25 | 0.000409 | 0.005072 |
GO:0036121 | double-stranded DNA helicase activity | 50.0% (1/2) | 11.25 | 0.000409 | 0.005072 |
GO:0045945 | positive regulation of transcription by RNA polymerase III | 50.0% (1/2) | 11.25 | 0.000409 | 0.005072 |
GO:0061383 | trabecula morphogenesis | 50.0% (1/2) | 11.25 | 0.000409 | 0.005072 |
GO:0021545 | cranial nerve development | 50.0% (1/2) | 11.08 | 0.00046 | 0.005154 |
GO:0048844 | artery morphogenesis | 50.0% (1/2) | 11.08 | 0.00046 | 0.005154 |
GO:0060021 | roof of mouth development | 50.0% (1/2) | 11.08 | 0.00046 | 0.005154 |
GO:0021772 | olfactory bulb development | 50.0% (1/2) | 11.45 | 0.000358 | 0.005178 |
GO:0036302 | atrioventricular canal development | 50.0% (1/2) | 11.45 | 0.000358 | 0.005178 |
GO:0048484 | enteric nervous system development | 50.0% (1/2) | 11.45 | 0.000358 | 0.005178 |
GO:0060123 | regulation of growth hormone secretion | 50.0% (1/2) | 11.45 | 0.000358 | 0.005178 |
GO:0061384 | heart trabecula morphogenesis | 50.0% (1/2) | 11.45 | 0.000358 | 0.005178 |
GO:0035116 | embryonic hindlimb morphogenesis | 50.0% (1/2) | 11.93 | 0.000256 | 0.005222 |
GO:0035113 | embryonic appendage morphogenesis | 50.0% (1/2) | 10.45 | 0.000716 | 0.005403 |
GO:0055008 | cardiac muscle tissue morphogenesis | 50.0% (1/2) | 10.45 | 0.000716 | 0.005403 |
GO:0060415 | muscle tissue morphogenesis | 50.0% (1/2) | 10.45 | 0.000716 | 0.005403 |
GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus | 50.0% (1/2) | 10.45 | 0.000716 | 0.005403 |
GO:0007628 | adult walking behavior | 50.0% (1/2) | 10.8 | 0.000563 | 0.005424 |
GO:0060324 | face development | 50.0% (1/2) | 10.8 | 0.000563 | 0.005424 |
GO:0060384 | innervation | 50.0% (1/2) | 10.8 | 0.000563 | 0.005424 |
GO:0090659 | walking behavior | 50.0% (1/2) | 10.8 | 0.000563 | 0.005424 |
GO:0021675 | nerve development | 50.0% (1/2) | 10.67 | 0.000614 | 0.005462 |
GO:0030540 | female genitalia development | 50.0% (1/2) | 10.67 | 0.000614 | 0.005462 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 50.0% (1/2) | 10.67 | 0.000614 | 0.005462 |
GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 50.0% (1/2) | 10.55 | 0.000665 | 0.005495 |
GO:0030326 | embryonic limb morphogenesis | 50.0% (1/2) | 10.55 | 0.000665 | 0.005495 |
GO:0030901 | midbrain development | 50.0% (1/2) | 10.55 | 0.000665 | 0.005495 |
GO:0001974 | blood vessel remodeling | 50.0% (1/2) | 10.93 | 0.000512 | 0.005548 |
GO:0007512 | adult heart development | 50.0% (1/2) | 11.67 | 0.000307 | 0.005606 |
GO:0035137 | hindlimb morphogenesis | 50.0% (1/2) | 11.67 | 0.000307 | 0.005606 |
GO:0006359 | regulation of transcription by RNA polymerase III | 50.0% (1/2) | 10.35 | 0.000767 | 0.005665 |
GO:0060303 | obsolete regulation of nucleosome density | 50.0% (1/2) | 10.25 | 0.000819 | 0.005917 |
GO:0048771 | tissue remodeling | 50.0% (1/2) | 10.08 | 0.000921 | 0.006521 |
GO:0008015 | blood circulation | 50.0% (1/2) | 9.93 | 0.001023 | 0.006574 |
GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress | 50.0% (1/2) | 9.93 | 0.001023 | 0.006574 |
GO:0060041 | retina development in camera-type eye | 50.0% (1/2) | 9.93 | 0.001023 | 0.006574 |
GO:0005705 | polytene chromosome interband | 50.0% (1/2) | 10.01 | 0.000972 | 0.006613 |
GO:0048806 | genitalia development | 50.0% (1/2) | 10.01 | 0.000972 | 0.006613 |
GO:0000779 | condensed chromosome, centromeric region | 50.0% (1/2) | 9.86 | 0.001074 | 0.006656 |
GO:0035108 | limb morphogenesis | 50.0% (1/2) | 9.86 | 0.001074 | 0.006656 |
GO:0060411 | cardiac septum morphogenesis | 50.0% (1/2) | 9.73 | 0.001177 | 0.007162 |
GO:0006369 | termination of RNA polymerase II transcription | 50.0% (1/2) | 9.61 | 0.001279 | 0.007651 |
GO:0042048 | olfactory behavior | 50.0% (1/2) | 9.5 | 0.001381 | 0.008122 |
GO:0071339 | MLL1 complex | 50.0% (1/2) | 9.45 | 0.001432 | 0.008283 |
GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 50.0% (1/2) | 9.4 | 0.001483 | 0.008438 |
GO:0007476 | imaginal disc-derived wing morphogenesis | 50.0% (1/2) | 9.3 | 0.001586 | 0.008597 |
GO:0007635 | chemosensory behavior | 50.0% (1/2) | 9.3 | 0.001586 | 0.008597 |
GO:0048514 | blood vessel morphogenesis | 50.0% (1/2) | 9.3 | 0.001586 | 0.008597 |
GO:0035114 | imaginal disc-derived appendage morphogenesis | 50.0% (1/2) | 9.25 | 0.001637 | 0.008737 |
GO:0001501 | skeletal system development | 50.0% (1/2) | 9.17 | 0.001739 | 0.008874 |
GO:0035120 | post-embryonic appendage morphogenesis | 50.0% (1/2) | 9.17 | 0.001739 | 0.008874 |
GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 50.0% (1/2) | 9.17 | 0.001739 | 0.008874 |
GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 50.0% (1/2) | 14.25 | 5.1e-05 | 0.008877 |
GO:2000270 | negative regulation of fibroblast apoptotic process | 50.0% (1/2) | 14.25 | 5.1e-05 | 0.008877 |
GO:0005703 | polytene chromosome puff | 50.0% (1/2) | 9.04 | 0.001892 | 0.00938 |
GO:0044665 | MLL1/2 complex | 50.0% (1/2) | 9.04 | 0.001892 | 0.00938 |
GO:0008344 | adult locomotory behavior | 50.0% (1/2) | 8.97 | 0.001995 | 0.009748 |
GO:0048565 | digestive tract development | 50.0% (1/2) | 8.9 | 0.002097 | 0.010105 |
GO:0030217 | T cell differentiation | 50.0% (1/2) | 8.76 | 0.002301 | 0.010647 |
GO:0040018 | positive regulation of multicellular organism growth | 50.0% (1/2) | 8.76 | 0.002301 | 0.010647 |
GO:0017116 | single-stranded DNA helicase activity | 50.0% (1/2) | 8.8 | 0.00225 | 0.010696 |
GO:2000177 | regulation of neural precursor cell proliferation | 50.0% (1/2) | 8.7 | 0.002403 | 0.010973 |
GO:0008013 | beta-catenin binding | 50.0% (1/2) | 8.64 | 0.002506 | 0.011292 |
GO:0001221 | transcription coregulator binding | 50.0% (1/2) | 8.53 | 0.00271 | 0.011468 |
GO:0007605 | sensory perception of sound | 50.0% (1/2) | 8.53 | 0.00271 | 0.011468 |
GO:0050954 | sensory perception of mechanical stimulus | 50.0% (1/2) | 8.53 | 0.00271 | 0.011468 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 50.0% (1/2) | 8.53 | 0.00271 | 0.011468 |
GO:0051282 | regulation of sequestering of calcium ion | 50.0% (1/2) | 8.58 | 0.002608 | 0.011601 |
GO:0060134 | prepulse inhibition | 50.0% (1/2) | 13.25 | 0.000102 | 0.011836 |
GO:0030534 | adult behavior | 50.0% (1/2) | 8.25 | 0.003272 | 0.012757 |
GO:0035107 | appendage morphogenesis | 50.0% (1/2) | 8.25 | 0.003272 | 0.012757 |
GO:0035067 | negative regulation of histone acetylation | 50.0% (1/2) | 8.35 | 0.003068 | 0.012825 |
GO:0002791 | regulation of peptide secretion | 50.0% (1/2) | 8.28 | 0.003221 | 0.012847 |
GO:0090276 | regulation of peptide hormone secretion | 50.0% (1/2) | 8.28 | 0.003221 | 0.012847 |
GO:0006353 | DNA-templated transcription termination | 50.0% (1/2) | 8.3 | 0.00317 | 0.01294 |
GO:0042110 | T cell activation | 50.0% (1/2) | 8.3 | 0.00317 | 0.01294 |
GO:2000757 | negative regulation of peptidyl-lysine acetylation | 50.0% (1/2) | 8.21 | 0.003374 | 0.013009 |
GO:0000775 | chromosome, centromeric region | 50.0% (1/2) | 8.13 | 0.003579 | 0.013645 |
GO:0035064 | methylated histone binding | 50.0% (1/2) | 8.01 | 0.003885 | 0.013898 |
GO:0140034 | methylation-dependent protein binding | 50.0% (1/2) | 8.01 | 0.003885 | 0.013898 |
GO:0002039 | p53 binding | 50.0% (1/2) | 8.03 | 0.003834 | 0.014004 |
GO:1901984 | negative regulation of protein acetylation | 50.0% (1/2) | 8.03 | 0.003834 | 0.014004 |
GO:0046883 | regulation of hormone secretion | 50.0% (1/2) | 8.04 | 0.003783 | 0.014114 |
GO:0090087 | regulation of peptide transport | 50.0% (1/2) | 8.04 | 0.003783 | 0.014114 |
GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 50.0% (1/2) | 7.86 | 0.004293 | 0.015202 |
GO:0007507 | heart development | 50.0% (1/2) | 7.81 | 0.004447 | 0.01543 |
GO:1903169 | regulation of calcium ion transmembrane transport | 50.0% (1/2) | 7.81 | 0.004447 | 0.01543 |
GO:0030098 | lymphocyte differentiation | 50.0% (1/2) | 7.78 | 0.004549 | 0.015628 |
GO:0040014 | regulation of multicellular organism growth | 50.0% (1/2) | 7.75 | 0.004651 | 0.015822 |
GO:0048477 | oogenesis | 50.0% (1/2) | 7.73 | 0.004702 | 0.01584 |
GO:0009886 | post-embryonic animal morphogenesis | 50.0% (1/2) | 7.72 | 0.004753 | 0.015858 |
GO:0035065 | regulation of histone acetylation | 50.0% (1/2) | 7.64 | 0.005008 | 0.016551 |
GO:0007292 | female gamete generation | 50.0% (1/2) | 7.6 | 0.005161 | 0.016738 |
GO:1903131 | mononuclear cell differentiation | 50.0% (1/2) | 7.6 | 0.005161 | 0.016738 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 50.0% (1/2) | 7.58 | 0.005212 | 0.016747 |
GO:0030178 | negative regulation of Wnt signaling pathway | 50.0% (1/2) | 7.55 | 0.005314 | 0.016918 |
GO:0007423 | sensory organ development | 50.0% (1/2) | 7.54 | 0.005365 | 0.016925 |
GO:0007626 | locomotory behavior | 50.0% (1/2) | 7.51 | 0.005467 | 0.016939 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 50.0% (1/2) | 7.51 | 0.005467 | 0.016939 |
GO:1901983 | regulation of protein acetylation | 50.0% (1/2) | 7.43 | 0.005774 | 0.017729 |
GO:0001701 | in utero embryonic development | 50.0% (1/2) | 7.4 | 0.005927 | 0.01804 |
GO:0002521 | leukocyte differentiation | 50.0% (1/2) | 7.3 | 0.006335 | 0.018949 |
GO:1990841 | promoter-specific chromatin binding | 50.0% (1/2) | 7.3 | 0.006335 | 0.018949 |
GO:0035097 | histone methyltransferase complex | 50.0% (1/2) | 7.27 | 0.006488 | 0.019241 |
GO:0046649 | lymphocyte activation | 50.0% (1/2) | 7.23 | 0.006641 | 0.019364 |
GO:0031057 | negative regulation of histone modification | 50.0% (1/2) | 7.24 | 0.00659 | 0.019378 |
GO:0007600 | sensory perception | 50.0% (1/2) | 7.19 | 0.006845 | 0.019792 |
GO:0035239 | tube morphogenesis | 50.0% (1/2) | 7.17 | 0.006947 | 0.019921 |
GO:0003678 | DNA helicase activity | 50.0% (1/2) | 7.14 | 0.0071 | 0.020193 |
GO:0060828 | regulation of canonical Wnt signaling pathway | 50.0% (1/2) | 7.08 | 0.007355 | 0.020748 |
GO:0045321 | leukocyte activation | 50.0% (1/2) | 7.02 | 0.007711 | 0.021579 |
GO:0034708 | methyltransferase complex | 50.0% (1/2) | 6.99 | 0.007864 | 0.021831 |
GO:0051924 | regulation of calcium ion transport | 50.0% (1/2) | 6.97 | 0.007966 | 0.021939 |
GO:0035295 | tube development | 50.0% (1/2) | 6.91 | 0.008272 | 0.022601 |
GO:0050890 | cognition | 50.0% (1/2) | 6.89 | 0.008425 | 0.022662 |
GO:0001775 | cell activation | 50.0% (1/2) | 6.9 | 0.008374 | 0.022701 |
GO:0140030 | modification-dependent protein binding | 50.0% (1/2) | 6.87 | 0.008527 | 0.02276 |
GO:0050767 | regulation of neurogenesis | 50.0% (1/2) | 6.71 | 0.009545 | 0.025284 |
GO:0043009 | chordate embryonic development | 50.0% (1/2) | 6.64 | 0.010004 | 0.026297 |
GO:0030111 | regulation of Wnt signaling pathway | 50.0% (1/2) | 6.62 | 0.010156 | 0.026498 |
GO:0048729 | tissue morphogenesis | 50.0% (1/2) | 6.6 | 0.010258 | 0.026564 |
GO:0051960 | regulation of nervous system development | 50.0% (1/2) | 6.49 | 0.011123 | 0.028591 |
GO:0007281 | germ cell development | 50.0% (1/2) | 6.47 | 0.011225 | 0.028641 |
GO:0048639 | positive regulation of developmental growth | 50.0% (1/2) | 6.45 | 0.011429 | 0.028737 |
GO:0008094 | ATP-dependent activity, acting on DNA | 50.0% (1/2) | 6.45 | 0.011378 | 0.028818 |
GO:1903530 | regulation of secretion by cell | 50.0% (1/2) | 6.4 | 0.011836 | 0.029335 |
GO:1904062 | regulation of cation transmembrane transport | 50.0% (1/2) | 6.4 | 0.011785 | 0.029419 |
GO:0003013 | circulatory system process | 50.0% (1/2) | 6.38 | 0.011988 | 0.029503 |
GO:0051046 | regulation of secretion | 50.0% (1/2) | 6.28 | 0.012853 | 0.031407 |
GO:0042393 | histone binding | 50.0% (1/2) | 6.2 | 0.013564 | 0.032914 |
GO:0060284 | regulation of cell development | 50.0% (1/2) | 6.14 | 0.014174 | 0.034155 |
GO:0004386 | helicase activity | 50.0% (1/2) | 6.1 | 0.01453 | 0.034532 |
GO:0098687 | chromosomal region | 50.0% (1/2) | 6.1 | 0.014479 | 0.034649 |
GO:0009792 | embryo development ending in birth or egg hatching | 50.0% (1/2) | 5.95 | 0.016103 | 0.037756 |
GO:0010959 | regulation of metal ion transport | 50.0% (1/2) | 5.95 | 0.016103 | 0.037756 |
GO:0008285 | negative regulation of cell population proliferation | 50.0% (1/2) | 5.92 | 0.016459 | 0.03833 |
GO:0031056 | regulation of histone modification | 50.0% (1/2) | 5.86 | 0.017169 | 0.039718 |
GO:0051703 | biological process involved in intraspecies interaction between organisms | 50.0% (1/2) | 5.83 | 0.017473 | 0.03989 |
GO:0048598 | embryonic morphogenesis | 50.0% (1/2) | 5.84 | 0.017372 | 0.039921 |
GO:0140097 | catalytic activity, acting on DNA | 50.0% (1/2) | 5.77 | 0.018234 | 0.041354 |
GO:0050877 | nervous system process | 50.0% (1/2) | 5.75 | 0.018538 | 0.041771 |
GO:0032774 | RNA biosynthetic process | 50.0% (1/2) | 5.72 | 0.018893 | 0.042296 |
GO:0007610 | behavior | 50.0% (1/2) | 5.7 | 0.019096 | 0.042476 |
GO:0007276 | gamete generation | 50.0% (1/2) | 5.65 | 0.019856 | 0.043607 |
GO:0031400 | negative regulation of protein modification process | 50.0% (1/2) | 5.65 | 0.019805 | 0.043773 |
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 50.0% (1/2) | 5.62 | 0.020261 | 0.044217 |
GO:0034765 | regulation of ion transmembrane transport | 50.0% (1/2) | 5.56 | 0.02102 | 0.045588 |
GO:0045927 | positive regulation of growth | 50.0% (1/2) | 5.52 | 0.021729 | 0.046832 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 50.0% (1/2) | 5.46 | 0.022539 | 0.047981 |
GO:0032102 | negative regulation of response to external stimulus | 50.0% (1/2) | 5.47 | 0.022488 | 0.048169 |
GO:0043066 | negative regulation of apoptotic process | 50.0% (1/2) | 5.44 | 0.022943 | 0.048545 |
GO:0034762 | regulation of transmembrane transport | 50.0% (1/2) | 5.42 | 0.023196 | 0.048782 |
GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 50.0% (1/2) | 5.41 | 0.023449 | 0.049017 |